Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome

Abstract

A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12–21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild–type chromosome, reflecting the need for inactivation of the wild–type allele at the predisposing locus. In four multiple case breast–ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild–type chromosome. This suggests that the putative ‘breast–ovarian’ cancer gene is indeed a tumour suppressor gene.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hall, J.M. et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684–1689 (1990).

    Article  CAS  PubMed  Google Scholar 

  2. Narod, S.A. et al. Familial breast-ovarian cancer locus on chromosome 17q12–q23. Lancet 338, 82–83 (1991).

    Article  CAS  PubMed  Google Scholar 

  3. Ponder, B.A.J. Gene losses in human tumours. Nature 335, 400–401 (1988).

    Article  CAS  PubMed  Google Scholar 

  4. Viskochil, D. et al. Deletions and translocations interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187–192 (1990).

    Article  CAS  PubMed  Google Scholar 

  5. Russell, S.E.H., Hickey, G.I., Lowry, W.S., White, P. & Atkinson, R.J. Allele loss from chromosome 17 in ovarian cancer. Oncogene 5, 1581–1583 (1990).

    CAS  PubMed  Google Scholar 

  6. Eccles, D.M., Cranston, G., Steel, C.M., Nakamura, Y. & Leonard, R.C.F. Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene 5, 1599–1601 (1990).

    CAS  PubMed  Google Scholar 

  7. Futreal, P.A. et al. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 52, 2624–2627 (1992).

    CAS  PubMed  Google Scholar 

  8. Steeg, P.S. et al. Evidence for a novel gene associated with low tumour metastatic potential. J. natn. Cancer Inst. 80, 200–204 (1988).

    Article  CAS  Google Scholar 

  9. Rosengard, A.M. et al. Reduced NM23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 342, 177–180 (1989).

    Article  CAS  PubMed  Google Scholar 

  10. Sato, T. et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res. 52, 1643–1646 (1992).

    CAS  PubMed  Google Scholar 

  11. Weber, J.L. et al. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucl. Acids Res. 18, 4640 (1990).

    PubMed  PubMed Central  Google Scholar 

  12. Hall, J.M. et al. Closing in on the breast cancer gene on chromosome 17q. Am. J. hum. Genet. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, S., Easton, D., Evans, D. et al. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome. Nat Genet 2, 128–131 (1992). https://doi.org/10.1038/ng1092-128

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1092-128

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing